Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-15 Purchase | 2024-02-20 5:38 pm | Prime Medicine Inc. | PRME | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. 10% Owner | 3,200,000 | $6.25 | $20,000,000 | 15,456,594 (Indirect) | View |
| 2023-11-13 Purchase | 2023-11-15 6:54 pm | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner | 35,010 | $11.77 | $412,140 | 4,131,207 (Indirect) | View |
| 2023-11-08 Purchase | 2023-11-13 7:00 pm | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner | 140,605 | $10.98 | $1,543,563 | 4,096,197 (Indirect) | View |
| 2023-11-03 Purchase | 2023-11-07 6:59 pm | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner | 95,694 | $11.49 | $1,099,945 | 3,955,592 (Indirect) | View |
| 2023-09-28 Purchase | 2023-09-29 6:53 pm | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner | 76,511 | $13.68 | $1,046,848 | 3,859,898 (Indirect) | View |
| 2023-09-26 Purchase | 2023-09-27 8:18 pm | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner | 58,504 | $11.97 | $700,464 | 3,783,387 (Indirect) | View |
| 2023-09-22 Purchase | 2023-09-25 9:38 pm | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner | 100,740 | $11.19 | $1,127,064 | 3,724,883 (Indirect) | View |
| 2023-09-19 Purchase | 2023-09-20 06:16 am | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 1,500,000 | $17 | $25,500,000 | 3,624,143 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion